SCHEMBL6677035

SCHEMBL6677035

Cc1ccc(S(=O)(=O)c2ccc(C[C@@H](C)NC(C(=O)OC(C)(C)C)[C@H](O)c3cccc(Cl)c3)cc2)c(/C=C/C(=O)O)c1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 14/20 0.36
ADRB1 P08588 11/20 0.36
ADRB2 P07550 11/20 0.36
CYP2D6 P10635 2/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CYP3A4 P08684 1/20 0.35
HIF1A Q16665 1/20 0.35
GLA P06280 1/20 0.34
SLC2A1 P11166 3/20 0.33
AKR1C3 P42330 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6677749 1.00 ADRB3 (0.36) ADRB3ADRB1ADRB2CYP2D6ADRA1D
SCHEMBL6682388 0.85 ADRB3 (0.38) ADRB3ADRB1ADRB2CYP2D6ADRA1D
SCHEMBL6695623 0.82 ADRB3 (0.35) ADRB3ADRB1ADRB2CYP2D6ADRA1D
SCHEMBL6805816 0.82 ADRB3 (0.55) ADRB3ADRB1ADRB2CYP2D6ADRA1D
SCHEMBL6805812 0.82 ADRB3 (0.55) ADRB3ADRB1ADRB2CYP2D6ADRA1D
SCHEMBL6805813 0.82 ADRB3 (0.55) ADRB3ADRB1ADRB2CYP2D6ADRA1D
Hydrochloric Acid SCHEMBL6679551 0.81 SLC2A1 (0.55) ADRB3ADRB1ADRB2CYP2D6ADRA1D
Hydrochloric Acid SCHEMBL6810369 0.81 SLC2A1 (0.55) ADRB3ADRB1ADRB2CYP2D6ADRA1D
Hydrochloric Acid SCHEMBL6676147 0.81 SLC2A1 (0.55) ADRB3ADRB1ADRB2CYP2D6ADRA1D
Hydrochloric Acid SCHEMBL6676141 0.81 SLC2A1 (0.55) ADRB3ADRB1ADRB2CYP2D6ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004045610-A1 AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD (JP) 2004-06-03 WO disclosed